Interventional Pulmonologist: Robotic Bronchoscopy & Nodule

HCA Healthcare; Cypress (TX); Sur place; USD 350 000 - 700 000; Plein temps

Avantages offerts par ce poste

Salary subsidy

Relocation and marketing allowance

Sign-On Bonus

Résumé du poste

HCA Houston Healthcare North Cypress seeks an interventional pulmonologist to join a busy private practice serving Cypress and the northwest Houston area. The role is outpatient-focused with a strong procedural emphasis, including ION robotic bronchoscopy.

The ideal candidate will have interventional fellowship training or experience, board certification or eligibility, and an active Texas medical license. There are growth opportunities, including leading the Lung Nodule Program and launching a

Qualifications

• Interventional fellowship training or experience in interventional pulmonary medicine.
• Board certified or board eligible with ability to obtain certification.
• Active Texas medical license or ability to obtain license.

Responsabilités

• Performing ION robotic bronchoscopy procedures.
• Leading and expanding our Lung Nodule Program, including participation in the Thoracic and Lung Nodule Conferences.
• Developing and launching an Endobronchial Valve (Zephyr Valve) program for patients with advanced emphysema.
• Supporting continued growth of interventional pulmonary services across Cypress and Tomball.
• Advanced practice providers manage a significant portion of the outpatient clinic volume, our procedural demand has increased substantially as the practice continues to grow.

Connaissances

Interventional pulmonology

Board certification

Description du poste

HCA Houston Healthcare North Cypress seeks an interventional pulmonologist to join a busy private practice serving Cypress and the northwest Houston area. The role is outpatient-focused with a strong procedural emphasis, including ION robotic bronchoscopy.

The ideal candidate will have interventional fellowship training or experience, board certification or eligibility, and an active Texas medical license. There are growth opportunities, including leading the Lung Nodule Program and launching a